Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Stemtech (STEK) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to $114514.0.

  • Stemtech's Change in Accured Expenses changed N/A to $114514.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 3631.57%. This contributed to the annual value of $1.8 million for FY2024, which is 8906.79% up from last year.
  • Stemtech's Change in Accured Expenses amounted to $114514.0 in Q3 2025.
  • In the past 5 years, Stemtech's Change in Accured Expenses ranged from a high of $1.1 million in Q1 2024 and a low of -$1.1 million during Q4 2022
  • Its 5-year average for Change in Accured Expenses is $229184.3, with a median of $258941.5 in 2021.
  • As far as peak fluctuations go, Stemtech's Change in Accured Expenses plummeted by 21331.27% in 2022, and later surged by 37724.09% in 2024.
  • Over the past 5 years, Stemtech's Change in Accured Expenses (Quarter) stood at $961638.0 in 2021, then tumbled by 213.31% to -$1.1 million in 2022, then surged by 111.82% to $128793.0 in 2023, then soared by 94.66% to $250713.0 in 2024, then tumbled by 54.32% to $114514.0 in 2025.
  • Its Change in Accured Expenses was $114514.0 in Q3 2025, compared to $347966.0 in Q2 2025 and $361521.0 in Q1 2025.